• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

寻找反映格雷夫斯眼眶病病程中眼眶组织重塑的参考生物标志物。

Search of reference biomarkers reflecting orbital tissue remodeling in the course of Graves' orbitopathy.

作者信息

Pawlowski Przemyslaw, Poplawska Izabela, Mysliwiec Janusz, Dik Willem A, Eckstein Anja, Berchner-Pfannschmidt Utta, Milewski Robert, Lawicki Slawomir, Dzieciol-Anikiej Zofia, Rejdak Robert, Reszec Joanna

机构信息

Department of Medical Pathomorphology, Cathedral of Biostructure, Medical University of Bialystok, Poland.

Department of Paediatric Ophthalmology and Strabismus, Medical University of Bialystok, Bialystok, Poland.

出版信息

Folia Histochem Cytobiol. 2020;58(1):37-45. doi: 10.5603/FHC.a2020.0003. Epub 2020 Mar 16.

DOI:10.5603/FHC.a2020.0003
PMID:32176314
Abstract

INTRODUCTION

Graves' orbitopathy (GO) is a complication in Graves' disease (GD) that causes disfigurement and sometimes blindness. The pathogenesis of GO remains unknown, while its symptoms demonstrate dependence between the thyroid gland and the orbit. The ongoing inflammatory process in retrobulbar tissue results in its remodeling characterized by increased volume of the orbital contents involving adipose tissue, with fibrosis and adipogenesis as predominant features. This study was aimed at the immunohistochemical verification of potential contribution and correlation between orbital expressions of IGF-1R, CD34, Foxp-3, PPAR-γ and CD4, CD68, TGF-β, FGF-β in severe and mild (long-lasting) GO.

MATERIAL AND METHODS

Forty-one orbital tissue specimens - 22 patients with severe GO, 9 patients with mild GO and 10 patients undergoing blepharoplasty as a control group - were processed by routine immunohistochemistry.

RESULTS

Increased IGF-1R, CD34 and Foxp-3 expression was found in both severe and mild GO, yet a significant correlation between CD34 and CD4, CD68, TGF-β, FGF-β expressions was observed in long-lasting GO.

CONCLUSIONS

CD34 expression is proposed to be the marker of orbital tissue remodeling in the course of mild GO.

摘要

引言

格雷夫斯眼眶病(GO)是格雷夫斯病(GD)的一种并发症,可导致容貌毁损,有时甚至失明。GO的发病机制尚不清楚,但其症状显示甲状腺与眼眶之间存在关联。球后组织中持续的炎症过程导致其重塑,其特征是眼眶内容物(包括脂肪组织)体积增加,以纤维化和脂肪生成为主要特征。本研究旨在通过免疫组织化学方法验证严重和轻度(长期)GO中IGF-1R、CD34、Foxp-3、PPAR-γ与CD4、CD68、TGF-β、FGF-β眼眶表达之间的潜在作用和相关性。

材料与方法

41份眼眶组织标本——22例严重GO患者、9例轻度GO患者以及10例行眼睑成形术的患者作为对照组——采用常规免疫组织化学方法进行处理。

结果

在严重和轻度GO中均发现IGF-1R、CD34和Foxp-3表达增加,但在长期GO中观察到CD34与CD4、CD68、TGF-β、FGF-β表达之间存在显著相关性。

结论

CD34表达被认为是轻度GO病程中眼眶组织重塑的标志物。

相似文献

1
Search of reference biomarkers reflecting orbital tissue remodeling in the course of Graves' orbitopathy.寻找反映格雷夫斯眼眶病病程中眼眶组织重塑的参考生物标志物。
Folia Histochem Cytobiol. 2020;58(1):37-45. doi: 10.5603/FHC.a2020.0003. Epub 2020 Mar 16.
2
Markers of inflammation and fibrosis in the orbital fat/connective tissue of patients with Graves' orbitopathy: clinical implications.格雷夫斯眼眶病患者眼眶脂肪/结缔组织中炎症和纤维化的标志物:临床意义
Mediators Inflamm. 2014;2014:412158. doi: 10.1155/2014/412158. Epub 2014 Sep 17.
3
Chemokine Expression during Adipogenesis and Inflammation in Orbital Fibroblasts from Patients with Graves' Orbitopathy.格雷夫斯眼眶病患者眼眶成纤维细胞脂肪生成和炎症过程中的趋化因子表达
Korean J Ophthalmol. 2020 Jun;34(3):192-202. doi: 10.3341/kjo.2020.0002.
4
Molecular biomarkers of Graves' ophthalmopathy.格雷夫斯眼病的分子生物标志物。
Exp Mol Pathol. 2019 Feb;106:1-6. doi: 10.1016/j.yexmp.2018.11.004. Epub 2018 Nov 8.
5
Current perspectives on the role of orbital fibroblasts in the pathogenesis of Graves' ophthalmopathy.眼眶成纤维细胞在格雷夫斯眼病发病机制中作用的当前观点
Exp Eye Res. 2016 Jan;142:83-91. doi: 10.1016/j.exer.2015.02.007.
6
Characterisation of human orbital fibroblasts cultivated from intraconal, nasal and central adipose tissues.从眶内、鼻腔和中央脂肪组织培养的人眼眶成纤维细胞的特征。
Br J Ophthalmol. 2021 Feb;105(2):290-296. doi: 10.1136/bjophthalmol-2018-313699. Epub 2019 Sep 5.
7
Fibroblast Growth Factor Receptor Inhibitors Reduce Adipogenesis of Orbital Fibroblasts and Enhance Myofibroblastic Differentiation in Graves' Orbitopathy.成纤维细胞生长因子受体抑制剂可减少眼眶成纤维细胞的脂肪生成并增强格雷夫斯眼病中的肌成纤维细胞分化。
Ocul Immunol Inflamm. 2021 Jan 2;29(1):193-202. doi: 10.1080/09273948.2019.1672196. Epub 2019 Oct 28.
8
Evidence for enhanced Thy-1 (CD90) expression in orbital fibroblasts of patients with Graves' ophthalmopathy.Graves眼病患者眼眶成纤维细胞中Thy-1(CD90)表达增强的证据。
Thyroid. 2008 Dec;18(12):1291-6. doi: 10.1089/thy.2008.0255.
9
Human placenta-derived mesenchymal stem cells ameliorate orbital adipogenesis in female mice models of Graves' ophthalmopathy.人胎盘源间充质干细胞改善格雷夫斯眼病女性小鼠模型眼眶脂肪生成。
Stem Cell Res Ther. 2019 Aug 9;10(1):246. doi: 10.1186/s13287-019-1348-0.
10
MicroRNA-27 inhibits adipogenic differentiation in orbital fibroblasts from patients with Graves' orbitopathy.微小 RNA-27 抑制格雷夫斯眼病患者眼眶成纤维细胞的成脂分化。
PLoS One. 2019 Aug 15;14(8):e0221077. doi: 10.1371/journal.pone.0221077. eCollection 2019.

引用本文的文献

1
Targeted Delivery of CD34 Aptamer-Coupled Tocilizumab Microspheres for Effective Treatment of Thyroid-Associated Ophthalmopathy.靶向递送CD34适配体偶联的托珠单抗微球用于有效治疗甲状腺相关眼病
Invest Ophthalmol Vis Sci. 2025 Aug 1;66(11):57. doi: 10.1167/iovs.66.11.57.
2
Immunological Processes in the Orbit and Indications for Current and Potential Drug Targets.眼眶中的免疫过程以及当前和潜在药物靶点的适应症
J Clin Med. 2023 Dec 22;13(1):72. doi: 10.3390/jcm13010072.
3
MiR-143 Targets IGF-1R to Suppress Autoimmunity in Thyroid-Associated Ophthalmopathy.
微小RNA-143靶向胰岛素样生长因子-1受体以抑制甲状腺相关性眼病中的自身免疫反应。
J Inflamm Res. 2022 Mar 1;15:1543-1554. doi: 10.2147/JIR.S339483. eCollection 2022.
4
Fight against fibrosis in adipose tissue remodeling.对抗脂肪组织重塑中的纤维化。
Am J Physiol Endocrinol Metab. 2021 Jul 1;321(1):E169-E175. doi: 10.1152/ajpendo.00558.2020. Epub 2021 May 31.
5
Mechanisms That Underly T Cell Immunity in Graves' Orbitopathy.甲状腺眼病中 T 细胞免疫的作用机制。
Front Endocrinol (Lausanne). 2021 Apr 1;12:648732. doi: 10.3389/fendo.2021.648732. eCollection 2021.